Comstock Inc.
LODE NYSE Industrial Organic Chemicals Financials FY2016βFY2025
Last close Β· Oct 23, 2026
$1.71
5.0%What Comstock Inc. does
No business description yet.
- Legal name
- Comstock Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 24, 2026
- Accession Β· CIK
- 0001437749-26-009589
0001120970
Revenue and margins
Comstock Inc. had $1.6M of revenue in fiscal 2025, down 48.5% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Comstock Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 120.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Comstock Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $5.9M | $2.5M | $22.7M | $1.0M | $17.0M |
| Debt incl. finance leases | $18.2M | $8.7M | $10.7M | $9.0M | $0.0M |
| Debt / equity | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Interest coverage | β37.9x | β11.7x | β7.7x | β13.3x | β19.8x |
| Current ratio | 0.6x | 1.0x | 1.6x | 1.5x | 2.1x |
| Quick ratio | 0.6x | 1.0x | 1.6x | 1.5x | 2.1x |
| Total assets | $127M | $100M | $106M | $91.3M | $170M |
| Total liabilities | $34.0M | $43.7M | $28.2M | $31.5M | $58.7M |
| Shareholders' equity | $89.6M | $53.6M | $78.3M | $59.8M | $108M |
| Net debt (β = net cash) | $12.3M | $6.2M | β$12.0M | $8.0M | β$17.0M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 5 / 8 | 3 / 8 | 5 / 8 | 3 / 9 | 3 / 9 | 5 / 9 | 2 / 9 | 4 / 9 |
| Accruals ratio | β30.6% | β12.5% | β18.3% | β4.4% | 45.2% | β20.1% | β30.5% | 22.1% | β39.8% | β14.3% |
| Altman Z'' | β20.60 | β23.31 | β26.25 | β17.35 | β12.18 | β4.40 | β9.57 | β6.01 | β12.59 | β6.46 |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $5.1M | $0.1M | $0.2M | $0.2M | $0.2M | $0.9M | $0.2M | $1.3M | $3.0M | $1.6M |
| Gross profit | β | β | β | β | $0.1M | $0.6M | $0.2M | $1.3M | $2.6M | β$1.1M |
| Research and development | β | β | β | β | $0.0M | $0.4M | $7.0M | $6.1M | $19.1M | $12.3M |
| Operating income | β$10.2M | β$8.9M | β$7.4M | β$5.3M | β$5.5M | β$6.4M | β$19.4M | β$12.6M | β$39.7M | β$38.1M |
| Interest expense | $0.8M | $1.7M | $1.4M | $0.9M | $0.4M | $0.2M | $1.7M | $1.6M | $3.0M | $1.9M |
| Pretax income | β$13.0M | β$10.6M | β$9.5M | β$3.8M | $14.9M | β$30.3M | β$46.7M | β | $53.3M | $43.1M |
| Income tax | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | β$5.7M | $0.0M | $0.0M | $0.0M | $0.0M |
| Net income | β$13.0M | β$10.6M | β$9.5M | β$3.8M | $14.9M | β$24.6M | β$46.7M | $9.2M | β$53.3M | β$43.1M |
| Net income to common | β$13.0M | β$10.6M | β | β$3.8M | $14.9M | β$24.6M | β$45.9M | $9.2M | β | β |
| Diluted EPS | β$0.37 | β$0.26 | β$0.79 | β$0.20 | $0.49 | β$0.49 | β$0.62 | $0.87 | β$3.21 | β$1.17 |
| Diluted shares | 0.04B | 0.04B | 0.01B | 0.02B | 0.03B | 0.05B | 0.07B | 0.01B | 0.02B | 0.04B |
| Cash flow | ||||||||||
| Cash from operations | β$2.6M | β$6.5M | β$4.0M | β$2.3M | β$3.8M | β$7.5M | β$12.1M | β$13.6M | β$13.9M | β$24.4M |
| Capital expenditure | $0.7M | $0.1M | $1.7M | $2.4M | $0.1M | $0.1M | $1.0M | $1.8M | β | β |
| Free cash flow | β$3.3M | β$6.7M | β$5.7M | β$4.7M | β$3.9M | β$7.6M | β$13.1M | β$15.4M | β | β |
| Depreciation and amortization | $5.9M | $4.2M | $3.1M | $1.8M | $1.2M | $1.0M | $3.3M | $2.5M | $2.2M | $3.8M |
| Stock-based compensation | $0.0M | $0.0M | $0.0M | $0.0M | $0.2M | $0.5M | $0.5M | β$0.0M | $0.0M | $0.0M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $0.2M | $2.1M | $0.5M | $1.0M | $2.4M | $5.9M | $2.5M | $22.7M | $1.0M | $17.0M |
| Total debt | $9.5M | $10.3M | $9.2M | $5.4M | $3.6M | $4.5M | $7.9M | $9.9M | $8.5M | $0.0M |
| Finance lease liabilities | β | β | β | β | β | $13.7M | $0.8M | $0.8M | $0.5M | β |
| Deposits | β | β | β | β | β | β | $0.4M | $0.4M | β | β |
| Current assets | $8.0M | $7.7M | $8.6M | $13.3M | $20.8M | $13.8M | $30.8M | $23.2M | $12.6M | $20.7M |
| Current liabilities | $2.4M | $1.1M | $2.4M | $4.4M | $4.8M | $23.9M | $31.6M | $14.8M | $8.1M | $10.0M |
| Inventory | $0.0M | β | β | β | β | β | β | β | β | β |
| Property and equipment, net | $15.1M | $12.8M | $9.7M | $7.9M | $8.6M | $14.6M | $13.5M | $15.2M | $8.6M | $29.9M |
| Goodwill | β | β | β | β | $0.0M | $12.8M | $0.0M | β | $0.0M | $1.5M |
| Intangible assets | β | β | β | β | $0.0M | $23.2M | $17.7M | $15.9M | $5.9M | $24.9M |
| Total assets | $33.8M | $31.0M | $28.6M | $39.6M | $43.1M | $127M | $100M | $106M | $91.3M | $170M |
| Total liabilities | $19.4M | $19.1M | $19.2M | $16.1M | $11.3M | $34.0M | $43.7M | $28.2M | $31.5M | $58.7M |
| Preferred stock | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Shareholders' equity | $14.4M | $11.9M | $9.4M | $23.2M | $31.8M | $89.6M | $53.6M | $78.3M | $59.8M | $108M |
| Margins | ||||||||||
| Gross margin | β | β | β | β | 74.3% | 68.4% | 100.0% | 100.0% | 85.0% | β69.1% |
| Operating margin | β201.4% | β8,512.0% | β4,923.8% | β2,975.8% | β2,714.1% | β743.0% | β10,864.9% | β989.0% | β1,315.1% | β2,455.2% |
| EBITDA margin | β85.2% | β4,496.9% | β2,829.3% | β1,964.0% | β2,108.0% | β623.0% | β8,997.0% | β794.6% | β1,240.8% | β2,207.9% |
| Net margin | β255.7% | β10,140.2% | β6,307.9% | β2,118.7% | 7,403.1% | β2,851.3% | β26,228.0% | 718.9% | β1,767.8% | β2,772.3% |
| FCF margin | β66.0% | β6,389.7% | β3,781.0% | β2,641.2% | β1,931.3% | β878.1% | β7,362.1% | β1,211.9% | β | β |
| Returns | ||||||||||
| Return on capital | β34.0% | β35.0% | β32.4% | β15.3% | β16.6% | β5.7% | β25.9% | β15.2% | β58.9% | β42.1% |
| Return on capital employed | β32.5% | β29.7% | β28.2% | β15.2% | β14.3% | β6.2% | β28.3% | β13.8% | β47.7% | β23.9% |
| Return on equity | β89.9% | β80.5% | β89.2% | β23.3% | 54.3% | β40.5% | β65.3% | 13.9% | β77.3% | β51.5% |
| Return on assets | β38.3% | β32.6% | β31.8% | β11.2% | 36.1% | β28.9% | β41.2% | 8.9% | β53.9% | β33.0% |
| Return on tangible equity | β89.9% | β89.1% | β101.0% | β16.4% | 47.0% | β45.9% | β127.9% | 14.7% | β98.9% | β53.1% |
| Growth | ||||||||||
| Revenue growth | β | β97.9% | 44.1% | 19.5% | 12.3% | 327.5% | β79.3% | 615.2% | 136.7% | β48.5% |
| Net income growth | β | β | β | β | β | β264.6% | β | β | β682.0% | β |
| EPS growth | β | β | β | β | β | β200.0% | β | β | β469.0% | β |
| Share count change | β | 16.4% | β71.0% | 63.1% | 57.1% | 65.0% | 47.7% | β85.9% | 58.0% | 120.9% |
| Financial health | ||||||||||
| Debt / equity | 0.7x | 0.9x | 1.0x | 0.2x | 0.1x | 0.1x | 0.1x | 0.1x | 0.1x | 0.0x |
| Interest coverage | β13.6x | β5.2x | β5.2x | β6.1x | β13.0x | β37.9x | β11.7x | β7.7x | β13.3x | β19.8x |
| Current ratio | 3.3x | 7.0x | 3.6x | 3.0x | 4.3x | 0.6x | 1.0x | 1.6x | 1.5x | 2.1x |
| Quick ratio | 3.3x | 7.0x | 3.6x | 3.0x | 4.3x | 0.6x | 1.0x | 1.6x | 1.5x | 2.1x |
| Capital allocation | ||||||||||
| Capex / revenue | 14.7% | 124.8% | 1,101.7% | 1,356.6% | 64.8% | 9.1% | 569.1% | 142.7% | β | β |
| Stock comp / revenue | 0.4% | 0.0% | 0.0% | 0.0% | 101.2% | 53.8% | 270.5% | β0.2% | 1.4% | 0.0% |
| Quality scores | ||||||||||
| Piotroski F-score | β | 3.0 | 5.0 | 3.0 | 5.0 | 3.0 | 3.0 | 5.0 | 2.0 | 4.0 |
| Altman Z'' | β20.6 | β23.3 | β26.3 | β17.3 | β12.2 | β4.4 | β9.6 | β6.0 | β12.6 | β6.5 |
| Accruals ratio | β30.6% | β12.5% | β18.3% | β4.4% | 45.2% | β20.1% | β30.5% | 22.1% | β39.8% | β14.3% |
Source: SEC EDGAR XBRL filings (CIK 0001120970). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.